Dane Andreeff
President & CEO
Helius Medical Technologies, Inc.
Helius Medical Technologies develops the Portable Neuromodulation Stimulator (PoNS®), a non-implantable device that delivers neurostimulation through the tongue to enhance neuroplasticity and improve motor function. This technology specifically targets individuals with neurological disorders and mild-to-moderate traumatic brain injury, aiming to increase their independence and quality of life.
- Digital Health
- Hardware
- Healthcare Technology
- Medical Devices
Updated 5 months ago
Funding
Raised to date
$6.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Individuals with neurological disorders and mild-to-moderate traumatic brain injury often experience impaired motor function, impacting their independence and quality of life. Traditional rehabilitation methods may not fully restore lost function, leaving a need for innovative therapies that enhance neuroplasticity.
Solution
Helius Medical Technologies offers the Portable Neuromodulation Stimulator (PoNS), a non-implantable device that delivers neurostimulation through the tongue to improve motor function. The PoNS device is used in conjunction with physical exercises and is designed to amplify the brain's ability to compensate for neurologic deficits and promote neuroplasticity. Clinical studies have demonstrated that the PoNS device can improve the effectiveness of physical exercises in people with neurological symptoms.
Target Audience
The primary target audience includes individuals with neurological disorders and mild-to-moderate traumatic brain injury seeking to improve their motor function and overall quality of life, as well as the clinicians who treat them.
Features
- Non-implantable device delivering neurostimulation via the tongue
- Designed to enhance neuroplasticity and improve motor function
- Intended for use in conjunction with physical exercises
- Targets neurological symptoms resulting from disease or trauma, including mild-to-moderate traumatic brain injury